Intlekofer, Andrew Michael

Publications

Sort by

Co-Author Network

selected publications

Rituximab and lenalidomide for the treatment of relapsed or refractory indolent non-Hodgkin lymphoma: real-life experience. Haematologica. 2024 Academic Article GET IT
CD8+ T cell metabolic flexibility elicited by CD28-ARS2 axis-driven alternative splicing of PKM supports antitumor immunity. Cellular & molecular immunology. 2024 Academic Article GET IT
Retrospective characterization of nodal marginal zone lymphoma. Blood advances. 2023 Review GET IT
TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy. Blood advances. 2023 Academic Article GET IT
D-2HG comes out of its shell: Metabolic effects on the immune environment. Molecular cell. 2022 Academic Article GET IT
Times cited: 1
Mitonuclear genotype remodels the metabolic and microenvironmental landscape of Hürthle cell carcinoma. Science advances. 2022 Academic Article GET IT
GCN2 kinase activation by ATP-competitive kinase inhibitors. Nature chemical biology. 2021 Academic Article GET IT
Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2021 Academic Article GET IT
Times cited: 122
In vivo library screening identifies the metabolic enzyme aldolase A as a promoter of metastatic lung colonization. iScience. 2021 Academic Article GET IT
Discovery of Protein Modifications Using Differential Tandem Mass Spectrometry Proteomics. Journal of proteome research. 2021 Academic Article GET IT
OncoTree: A Cancer Classification System for Precision Oncology. JCO clinical cancer informatics. 2021 Academic Article GET IT
FXR mediates T cell-intrinsic responses to reduced feeding during infection. Proceedings of the National Academy of Sciences of the United States of America. 2020 Academic Article GET IT
Times cited: 22
The epigenomics of sarcoma. Nature reviews. Cancer. 2020 Information Resource GET IT
Times cited: 141
Specific patterns of H3K79 methylation influence genetic interaction of oncogenes in AML. Blood advances. 2020 Academic Article GET IT
Times cited: 3
Nitrogen Trapping as a Therapeutic Strategy in Tumors with Mitochondrial Dysfunction. Cancer research. 2020 Academic Article GET IT
Times cited: 10
Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesis. Nature. 2019 Academic Article GET IT
Times cited: 155
Using genomic data for selecting the treatment of lymphoma patients. Current opinion in hematology. 2019 Information Resource GET IT
Times cited: 2
Metabolic signatures of cancer cells and stem cells. Nature metabolism. 2019 Information Resource GET IT
Times cited: 225
Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay. Blood cancer journal. 2018 Academic Article GET IT
Times cited: 28
JAK2/IDH-mutant-driven myeloproliferative neoplasm is sensitive to combined targeted inhibition. The Journal of clinical investigation. 2018 Academic Article GET IT
Times cited: 60
As Extracellular Glutamine Levels Decline, Asparagine Becomes an Essential Amino Acid. Cell metabolism. 2018 Academic Article GET IT
Times cited: 227
Epigenetic Identity in AML Depends on Disruption of Nonpromoter Regulatory Elements and Is Affected by Antagonistic Effects of Mutations in Epigenetic Modifiers. Cancer discovery. 2017 Academic Article GET IT
Times cited: 99
L-2-Hydroxyglutarate production arises from noncanonical enzyme function at acidic pH. Nature chemical biology. 2017 Academic Article GET IT
Times cited: 189
Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in IDH2- and TET2-Mutant Acute Myeloid Leukemia. Cancer discovery. 2017 Academic Article GET IT
Times cited: 99
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice. Cancer cell. 2016 Academic Article GET IT
Times cited: 195
Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting. Blood. 2016 Academic Article GET IT
Times cited: 251
Hypoxia Induces Production of L-2-Hydroxyglutarate. Cell metabolism. 2015 Academic Article GET IT
Times cited: 377
Genomic and functional analysis of leukemic transformation of myeloproliferative neoplasms. Proceedings of the National Academy of Sciences of the United States of America. 2014 Academic Article GET IT
Times cited: 244
Precision therapy for lymphoma--current state and future directions. Nature reviews. Clinical oncology. 2014 Information Resource GET IT
Times cited: 58
Induction of sarcomas by mutant IDH2. Genes & development. 2013 Academic Article GET IT
Times cited: 135
A case of advanced gastric cancer. 2012 GET IT
Transcription factor T-bet represses expression of the inhibitory receptor PD-1 and sustains virus-specific CD8+ T cell responses during chronic infection. Nature immunology. 2011 Academic Article GET IT
Times cited: 395
Cutting edge: Lymphoproliferation caused by Fas deficiency is dependent on the transcription factor eomesodermin. Journal of immunology (Baltimore, Md. : 1950). 2010 Academic Article GET IT
Times cited: 16
Cutting edge: The transcription factor eomesodermin enables CD8+ T cells to compete for the memory cell niche. Journal of immunology (Baltimore, Md. : 1950). 2010 Academic Article GET IT
Times cited: 322
A role for the transcriptional repressor Blimp-1 in CD8(+) T cell exhaustion during chronic viral infection. Immunity. 2009 Academic Article GET IT
Times cited: 382
Pre-TCR signaling inactivates Notch1 transcription by antagonizing E2A. Genes & development. 2009 Academic Article GET IT
Times cited: 144
Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesodermin. Science (New York, N.Y.). 2008 Academic Article GET IT
Times cited: 327
Requirement for T-bet in the aberrant differentiation of unhelped memory CD8+ T cells. The Journal of experimental medicine. 2007 Academic Article GET IT
Times cited: 230
Asymmetric T lymphocyte division in the initiation of adaptive immune responses. Science (New York, N.Y.). 2007 Academic Article GET IT
Times cited: 601
Epigenetic and transcriptional programs lead to default IFN-gamma production by gammadelta T cells. Journal of immunology (Baltimore, Md. : 1950). 2007 Academic Article GET IT
Times cited: 49
Expression of the transcription factor cKrox in peripheral CD8 T cells reveals substantial postthymic plasticity in CD4-CD8 lineage differentiation. The Journal of experimental medicine. 2007 Academic Article GET IT
Times cited: 62
Cutting Edge: IL-12 inversely regulates T-bet and eomesodermin expression during pathogen-induced CD8+ T cell differentiation. Journal of immunology (Baltimore, Md. : 1950). 2006 Academic Article GET IT
Times cited: 246
Not-so-great expectations: re-assessing the essence of T-cell memory. Immunological reviews. 2006 Information Resource GET IT
Times cited: 21
Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. Nature immunology. 2005 Academic Article GET IT
Times cited: 813

more ...

less ...

Background

education and training

M.D., University of Pennsylvania School of Medicine 2009
Ph.D., University of Pennsylvania 2007
B.S., University of Maryland 2001

Contact

full name

Andrew Michael Intlekofer

VIVO Weill Cornell Medical College

Andrew Michael Intlekofer Assistant Professor of Medicine

Publications

selected publications

Background

education and training

Contact

full name

Phone

Publications

selected publications

Background

education and training

Contact

full name